Correlation Between INtRON Biotechnology and Eugene Technology

Can any of the company-specific risk be diversified away by investing in both INtRON Biotechnology and Eugene Technology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining INtRON Biotechnology and Eugene Technology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between iNtRON Biotechnology and Eugene Technology CoLtd, you can compare the effects of market volatilities on INtRON Biotechnology and Eugene Technology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in INtRON Biotechnology with a short position of Eugene Technology. Check out your portfolio center. Please also check ongoing floating volatility patterns of INtRON Biotechnology and Eugene Technology.

Diversification Opportunities for INtRON Biotechnology and Eugene Technology

0.51

Correlation Coefficient

INtRON Biotechnology  Eugene Technology

Very weak diversification

The 3 months correlation between INtRON and Eugene is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding iNtRON Biotechnology and Eugene Technology CoLtd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eugene Technology CoLtd and INtRON Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on iNtRON Biotechnology are associated (or correlated) with Eugene Technology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eugene Technology CoLtd has no effect on the direction of INtRON Biotechnology i.e., INtRON Biotechnology and Eugene Technology go up and down completely randomly.

Pair Corralation between INtRON Biotechnology and Eugene Technology

Assuming the 90 days trading horizon iNtRON Biotechnology is expected to generate 1.16 times more return on investment than Eugene Technology. However, INtRON Biotechnology is 1.16 times more volatile than Eugene Technology CoLtd. It trades about 0.01 of its potential returns per unit of risk. Eugene Technology CoLtd is currently generating about -0.02 per unit of risk. If you would invest  589,000  in iNtRON Biotechnology on September 18, 2024 and sell it today you would lose (4,000) from holding iNtRON Biotechnology or give up 0.68% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

iNtRON Biotechnology  vs.  Eugene Technology CoLtd

iNtRON Biotechnology

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in iNtRON Biotechnology are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, INtRON Biotechnology is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Eugene Technology CoLtd

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Eugene Technology CoLtd has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Eugene Technology is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with INtRON Biotechnology and Eugene Technology

The main advantage of trading using opposite INtRON Biotechnology and Eugene Technology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if INtRON Biotechnology position performs unexpectedly, Eugene Technology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eugene Technology will offset losses from the drop in Eugene Technology's long position.

The idea behind iNtRON Biotechnology and Eugene Technology CoLtd pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.